Interferon Inducible IFI16 Expression in p16 Positive Squamous Cell Carcinoma of the Oropharynx

Table 1

Clinicopathological parameters, p16, and IFI16 detection in 22 oropharyngeal SCC.

Case	Age	Sex	Primary site	T	N	M	Stage	p16	IFI16	Followup, months
1	60	M	PT	1	2c	0	IVA	Neg.	Neg.	NED 60
2	70	M	PT	3	2b	0	IVA	Neg.	Neg.	DWD 14
3	42	M	PT	4a	3	0	IVB	Neg.	Neg.	DWD 2
4	78	M	BOT	3	0	0	III	Neg.	Neg.	NED 4
5	63	M	PT	2	0	0	II	Neg.	Neg.	NED 14
6	55	M	PT	2	2b	0	IVA	Pos.	Neg.	NED 108
7	62	M	PT	2	0	0	II	Pos.	Neg.	NED 108
8	37	M	PT	4a	2b	0	IVA	Pos.	Neg.	NED 56
9	61	M	PT	3	3	0	IVB	Pos.	Neg.	NED 35
10	68	M	PT	3	2b	0	IVA	Pos.	Neg.	NED 46
11	64	M	PT	2	2b	0	IVA	Pos.	Neg.	NED 42
12	49	M	PT	2	2c	0	IVA	Pos.	Neg.	NED 9
13	76	M	PT	4b	3	1	IVB	Neg.	Pos.	DWD 2
14	84	F	PT	4a	2b	0	IVA	Neg.	Pos.	DWD 12
15	55	F	PT	1	1	0	III	Neg.	Pos.	NED 40
16	42	M	PT	1	2b	0	IVA	Pos.	Pos.	NED 47
17	49	M	PT	2	2b	0	IVA	Pos.	Pos.	NED 47
18	55	M	PT	2	2b	0	IVA	Pos.	Pos.	NED 46
19	73	M	PT	3	2c	0	IVA	Pos.	Pos.	NED 6
20	70	M	PT	4b	2b	0	IVB	Pos.	Pos.	DWD 1
21	61	M	BOT	2	0	0	II	Pos.	Pos.	NED 39
22	66	M	PT	1	2b	0	IVA	Pos.	Pos.	NED 12

PT: palatine tonsil; BOT: base of tongue; Neg.: negative; Pos.: positive; NED: no evidence of disease; DWD: died with disease.